95 related articles for article (PubMed ID: 80945)
1. Baisc protein hydrolysis in lymphocytes of Lewis rats with experimental allergic encephalomyelitis.
SMith ME
Adv Exp Med Biol; 1978; 100():347-63. PubMed ID: 80945
[TBL] [Abstract][Full Text] [Related]
2. Neutral protease activity in lymphocytes of Lewis rats with acute experimental allergic encephalomyelitis.
Smith ME
Neurochem Res; 1979 Dec; 4(6):689-702. PubMed ID: 94652
[TBL] [Abstract][Full Text] [Related]
3. Partial purification and characterization of neutral proteases in lymph nodes of rats with experimental allergic encephalomyelitis.
Smith ME; Chow SH; Rolph RH
Neurochem Res; 1981 Aug; 6(8):901-12. PubMed ID: 6171741
[TBL] [Abstract][Full Text] [Related]
4. A lymph node neutral proteinase acting on myelin basic protein.
Smith ME
J Neurochem; 1976 Nov; 27(5):1077-82. PubMed ID: 12170591
[TBL] [Abstract][Full Text] [Related]
5. Enzymic hydrolysis of myelin basic protein and other proteins in central nervous system and lymphoid tissues from normal and demyelinating rats.
Buletza GF; Smith ME
Biochem J; 1976 Jun; 156(3):627-33. PubMed ID: 949344
[TBL] [Abstract][Full Text] [Related]
6. DNA changes in spinal cords of rats with experimental allergic encephalomyelitis.
Smith ME; Somera FP; Saldivar R; Massacesi L; Trotter J
J Neurochem; 1984 Dec; 43(6):1635-41. PubMed ID: 6208337
[TBL] [Abstract][Full Text] [Related]
7. Ellagic acid protects from myelin-associated sphingolipid loss in experimental autoimmune encephalomyelitis.
Busto R; Serna J; Perianes-Cachero A; Quintana-Portillo R; García-Seisdedos D; Canfrán-Duque A; Paino CL; Lerma M; Casado ME; Martín-Hidalgo A; Arilla-Ferreiro E; Lasunción MA; Pastor Ó
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Sep; 1863(9):958-967. PubMed ID: 29793057
[TBL] [Abstract][Full Text] [Related]
8. Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigen to B cells: evidence that the protective mechanism depends on changes in the cytokine response and migratory properties of the autoantigen-specific T cells.
Saoudi A; Simmonds S; Huitinga I; Mason D
J Exp Med; 1995 Aug; 182(2):335-44. PubMed ID: 7543135
[TBL] [Abstract][Full Text] [Related]
9. Proteolytic activity in CSF.
Richards PT; Cuzner ML
Adv Exp Med Biol; 1978; 100():521-7. PubMed ID: 80950
[TBL] [Abstract][Full Text] [Related]
10. Suppression of ongoing experimental allergic encephalomyelitis (EAE) in Lewis rats: synergistic effects of myelin basic protein (MBP) peptide 68-86 and IL-4.
Xu LY; Huang YM; Yang JS; Van Der Meide PH; Link H; Xiao BG
Clin Exp Immunol; 2000 Jun; 120(3):526-31. PubMed ID: 10844533
[TBL] [Abstract][Full Text] [Related]
11. Induction of recurrent experimental allergic encephalomyelitis with myelin basic protein.
Panitch H; Ciccone C
Ann Neurol; 1981 May; 9(5):433-8. PubMed ID: 6168235
[TBL] [Abstract][Full Text] [Related]
12. The significance of circulating and cell-bound antibodies in experimental allergic encephalomyelitis.
Gonatas NK; Gonatas JO; Stieber A; Lisak R; Suzuki K; Martenson RE
Am J Pathol; 1974 Sep; 76(3):529-48. PubMed ID: 4547331
[TBL] [Abstract][Full Text] [Related]
13. Acquired tolerance to experimental autoimmune encephalomyelitis by intrathymic injection of myelin basic protein or its major encephalitogenic peptide.
Khoury SJ; Sayegh MH; Hancock WW; Gallon L; Carpenter CB; Weiner HL
J Exp Med; 1993 Aug; 178(2):559-66. PubMed ID: 7688026
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99.
Liu JQ; Bai XF; Shi FD; Xiao BG; Li HL; Levi M; Mustafa M; Wahren B; Link H
Int Immunol; 1998 Aug; 10(8):1139-48. PubMed ID: 9723700
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppression of experimental allergic encephalomyelitis. III. In vitro evidence for induction of suppressor T lymphocytes in draining lymph node cells of animals immunized with myelin basic protein complexed to lipopolysaccharides.
Raziuddin S; Kibler RF; Morrison DC
J Immunol; 1982 May; 128(5):2073-80. PubMed ID: 6174621
[TBL] [Abstract][Full Text] [Related]
16. Chronic permeability of the central nervous system to mononuclear cells in experimental allergic encephalomyelitis in the Lewis rat.
Stohl W; Gonatas NK
J Immunol; 1978 Sep; 121(3):844-50. PubMed ID: 308523
[TBL] [Abstract][Full Text] [Related]
17. Propentofylline and iloprost suppress the production of TNF-alpha by macrophages but fail to ameliorate experimental autoimmune encephalomyelitis in Lewis rats.
Jung S; Donhauser T; Toyka KV; Hartung HP
J Autoimmun; 1997 Dec; 10(6):519-29. PubMed ID: 9451591
[TBL] [Abstract][Full Text] [Related]
18. Suppressive effect of camostat mesilate (FOY 305) on acute experimental allergic encephalomyelitis (EAE).
Inuzuka T; Sato S; Baba H; Miyatake T
Neurochem Res; 1988 Mar; 13(3):225-8. PubMed ID: 2455235
[TBL] [Abstract][Full Text] [Related]
19. Active immunization with complementary peptide PBM 9-1: preliminary evidence that it modulates experimental allergic encephalomyelitis in PL/J mice and Lewis rats.
Zhou SR; Whitaker JN
J Neurosci Res; 1996 Aug; 45(4):439-46. PubMed ID: 8872904
[TBL] [Abstract][Full Text] [Related]
20. Changes in cathepsins B-1 and D, neutral proteinase and 2',3'-cyclic nucleotide-3'-phosphohydrolase activities in monkey brain with experimental allergic encephalomyelitis.
Govindarajan KR; Rauch HC; Clausen J; Einstein ER
J Neurol Sci; 1974 Oct; 23(2):295-306. PubMed ID: 4139244
[No Abstract] [Full Text] [Related]
[Next] [New Search]
